GPCR University live courses we are preparing for you in 2024.

GPCR University We are excited to announce that Dr. Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals CB1 receptor inverse

Additionally, DMS is not universally applicable to all proteins; it struggles with proteins that lack of the technique, enabling more precise interpretations of how mutations affect protein function in diverse

GPCR University The wait is finally over!

GPCR University We are excited to announce that Dr.

., Direct interrogation of context-dependent GPCR activity with a universal biosensor platform. bioRxiv

GPCR University 🎥 Access to the recorded classes of GPCR Courses and talks from Symposia 💲 Discounted

Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554 Cardiff-based Antiverse raises €2.8M for its computational antibody drug discovery platform Antiverse identifies therapeutic

ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours A Conversation with Murat Tunaboylu, Antiverse

receptor MRGPRX1 Improved approaches to channel capacity estimation discover compromised GPCR signaling in diverse Presented At ENDO Novo Nordisk to Acquire Inversago Pharma GPCR Events, Meetings, and Webinars NEW Antiverse

(March 30, 2023) NEW Webinar - Antiverse: Engineering the Future of Drug Discovery (March 30, 2023) NEW

GPCR News  Let’s dive into the   Classified GPCR News from October 7th to 13th, 2024 Industry News Antiverse Computational Chemistry Postdoc in GPCR mechanosensing   Postdoctoral Position GPCR Activation and Signaling Diverse

Quarter and First Nine Months of 2024 Nasdaq debutante Septerna swells its IPO to $331m Nxera Pharma and Antiverse